| Extracellular vesicles in the Chronic Myeloid Leukemia scenario: an update about the shuttling of disease markers and therapeutic molecules S Bernardi, O Mulas, S Mutti, A Costa, D Russo, G La Nasa Frontiers in Oncology 13, 1239042, 2024 | 1 | 2024 |
| In Vitro Biocompatibility Assessment of Bioengineered PLA-Hydrogel Core–Shell Scaffolds with Mesenchymal Stromal Cells for Bone Regeneration F Re, L Sartore, C Pasini, M Ferroni, E Borsani, S Pandini, A Bianchetti, ... Journal of Functional Biomaterials 15 (8), 2024 | 1 | 2024 |
| Potentiality of Bone Marrow-Derived Mesenchymal Stromal Cells (BM-MSCs) to Differentiate into the Osteogenic Lineage in in Vitro Model of Tissue Regeneration F Re, L Sartore, E Borsani, M Ferroni, C Pasini, S Pandini, S Bernardi, ... Blood 142, 5626, 2023 | 1 | 2023 |
| Digital PCR (dPCR) is able to anticipate the achievement of stable deep molecular response in adult chronic myeloid leukemia patients: results of the DEMONSTRATE study S Bernardi, A Cavalleri, S Mutti, L Garuffo, M Farina, A Leoni, A Iurlo, ... Annals of Hematology, 1-11, 2024 | | 2024 |
| Correlation between BCR:: ABL1 Transcript LEVEL in Circulating Extracellular Vesicles and BOTH the Molecular Response and the Ongoing Therapy: A Study on Adult CML Patients S Bernardi, S Mutti, A Cavalleri, C Ielo, M Farina, F Re, K Bosio, A Leoni, ... Blood 142, 3180, 2023 | | 2023 |
| PB1959: BCR:: ABL1 TRANSCRIPT IN SMALL EXTRACELLULAR VESICLES ISOLATED IN ADULT CHRONIC MYELOID LEUKEMIA PATIENTS CORRELATES WITH MOLECULAR RESPONSE LEVEL AND THE ONGOING THERAPY S Bernardi, M Farina, F Re, A Cavalleri, S Mutti, K Bosio, A Leoni, ... HemaSphere 7 (S3), e4289079, 2023 | | 2023 |
